We found a significant reduction in the expression of PP2Ac protein level in BMDM cells at both 12 and 24 h-post infection upon TKI-nilotinib treatment as compared with untreated controlled cells (Figure 3A,B). The gene discussed is PPP2CA; the disease is infection.